ESC Premium Access

Comparative effectiveness and costs of enoxaparin versus unfractionated heparin in treating acute coronary syndrome

Congress Presentation

About the speaker

Mrs Andree Levorsen

0 follower

Access the full session

Poster Session 7 - Acute Coronary Syndromes - P2Y12 inhibitor

Speakers: Mrs A. Levorsen

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb